APH

Market Overview: The U.S. stock market experienced a 9% decline in less than a month, leading to an oversold condition that prompted a rally towards the declining 20-day moving average of the S&P 500 Index.

Resistance and Support Levels: The SPX faces resistance at 5,800, while support is found at recent lows around 5,500-5,540 and near 5,400, which corresponds to last September's lows.

Current Market Conditions: The S&P 500 index is attempting to recover from oversold levels, with recent lows around 5,500 indicating a support range.

Resistance and Moving Averages: An oversold rally typically targets the declining 20-day moving average at approximately 5,780, while resistance is expected around the 5,770 level, which was previously a support area.

Ethernet Alliance Interoperability Demo: The Ethernet Alliance will showcase its annual live interoperability demonstration at the 2025 Optical Fiber Communication Conference, highlighting advancements in Ethernet technology and its critical role in AI and high-speed networking.

10th Anniversary Ethernet Roadmap: The event will also feature the launch of the 2025 edition of the Ethernet Roadmap, which addresses key developments in high-speed Ethernet, AI integration, and sustainability, along with a panel discussion on interoperability challenges in hyperscale data centers.

NVIDIA's GTC 2025 Focus: CEO Jensen Huang will unveil advancements in AI hardware, with key attention on the Blackwell Ultra and Rubin platforms, which are critical for Nvidia suppliers and could influence investor sentiment across the hardware supply chain.

Potential Winners in Hardware Evolution: Companies like Super Micro, Dell, Amphenol, Coherent, and Fabrinet are expected to benefit from Nvidia's innovations, particularly as new chips demand increased power and cooling solutions, while networking firms may see changes in connectivity trends.

Nvidia's GTC Event Impact: J.P. Morgan does not anticipate Nvidia's annual GTC event to significantly alter the sentiment towards AI-related stocks, although it may positively impact some of Nvidia's suppliers like Amphenol and companies in the optical transceiver sector.

Keynote and Expectations: The GTC runs from March 17 to March 21, with CEO Jensen Huang delivering a keynote on March 18, where insights on co-package optics and traditional solutions for networking could be crucial for investor reassurance.

Upcoming Ex-Dividend Dates: Air Lease Corp, Amphenol Corp., and Hub Group, Inc. will trade ex-dividend on 3/18/25, with respective dividends of $0.22, $0.165, and $0.125 scheduled for payment in early April and late March 2025.

Market Impact and Dividend Yields: Following the ex-dividend date, shares are expected to open lower by approximately 0.49% for Air Lease Corp, 0.27% for Amphenol Corp, and 0.34% for Hub Group, with estimated annualized yields of 1.98%, 1.07%, and 1.37% respectively.

Current Market Status: The S&P 500 Index has fallen below all support levels, breaking the trading range established since last November, with tentative support at 5,525 and potential further support at 5,400.

Market Outlook: Although the U.S. market is oversold, confirmed buy signals are still lacking; any rallies may be temporary and likely to fade when approaching the declining 20-day moving average at 5,900.

Disclosure of Interests: Sand Grove Capital Management LLP disclosed a significant holding of 56,606,313 shares (10.47%) in Alliance Pharma plc as of March 7, 2025, under the Takeover Code's Rule 8.3.

Recent Transactions: The firm purchased an additional 1,560,010 shares at a price of 62.476p each, indicating active engagement in the market for the relevant securities.

Tariffs and Federal Spending Cuts Impact: Companies with software-driven hardware, like Cisco and Arista, are better positioned to handle tariffs, while device makers may struggle due to federal spending cuts affecting their revenue.

CoWoS Supply Chain Challenges: Nvidia's recent order cuts are impacting its supply chain partners, leading to potential valuation declines, although Cisco and Arista remain relatively insulated from these challenges.

Disclosure of Interests: Sand Grove Capital Management LLP disclosed its interest in Alliance Pharma plc, holding 55,046,303 relevant securities, representing 10.18% of the company as of March 6, 2025.

Recent Dealings: The firm made several purchases of ordinary shares on March 6, 2025, totaling 723,079 shares at prices ranging from 62.495p to 62.5p per unit.

Disclosure by Sand Grove Capital Management: Sand Grove Capital Management LLP disclosed its position in Alliance Pharma plc, holding 53,758,245 shares, which represents 9.94% of the company's relevant securities as of March 5, 2025.

Recent Transactions: The firm made purchases of 1,000,000 and 515,397 shares at prices of 62.5p and 62.49p respectively, with no other dealings or agreements reported related to options or derivatives.

52 Week Range of XLK: The XLK ETF has a 52-week low of $190.745 and a high of $243.14, with the last trade recorded at $217.59, indicating its current position relative to historical performance.

ETFs Trading Dynamics: ETFs function similarly to stocks, allowing for the buying and selling of units that can be created or destroyed based on investor demand, which affects the underlying holdings and market dynamics.

Company Overview: Amphenol Corporation, a large-cap tech company with a market cap of $74.8 billion, specializes in electrical and electronic connectors across various industries, including telecommunications and aerospace, but has recently faced stock declines despite strong Q4 earnings.

Market Performance: While Amphenol's stock has underperformed compared to the Nasdaq Composite over the past year, analysts maintain a "Strong Buy" consensus with a price target suggesting significant upside potential.

Disclosure by Sand Grove Capital Management: Sand Grove Capital Management LLP disclosed its interest in Alliance Pharma plc, holding 43,736,018 shares, which represents 8.09% of the company's relevant securities as of February 28, 2025.

Recent Transactions: The firm made two purchases of Alliance Pharma's ordinary shares, acquiring a total of 1,823,336 shares at prices ranging from 62.15p to 62.4883p per unit.

Market Performance: January 2025 saw solid U.S. stock market returns, continuing a trend of exceptional annual performance over the past two years, with insights from Chief Equity Strategist John Blank on market drivers and risks.

Investment Opportunities: Zacks Investment Research highlights five stocks expected to potentially double in value by 2024, emphasizing their low visibility on Wall Street as a unique investment opportunity.

SPYG Performance Overview: SPYG's share price is currently at $88.88, within a 52-week range of $68.48 to $92.76, and its performance can be analyzed using the 200-day moving average.

ETFs Trading Dynamics: Exchange traded funds (ETFs) operate like stocks, with units that can be created or destroyed based on investor demand, affecting the underlying holdings when there are significant inflows or outflows.

Analyst Ratings on Amphenol: Amit Daryanani from Evercore ISI maintains a Buy rating on Amphenol with a price target of $88.00, while the analyst consensus is a Strong Buy with an average target of $87.33, indicating a potential upside of 21.63% from current levels.

Analyst Performance: Daryanani is recognized as a 5-star analyst with a 14.2% average return and a 61.20% success rate, covering major technology stocks including Apple and IBM.

Company Overview and Performance: Amphenol Corporation, valued at $84.2 billion, is a global leader in connectors and interconnect systems, with shares rising 34.5% over the past year, outperforming the S&P 500 and Technology Select Sector SPDR Fund.

Earnings Report and Analyst Ratings: The company reported strong Q4 2024 earnings with a 34.1% increase in adjusted EPS, leading to a consensus rating of "Strong Buy" among analysts, with a price target suggesting a potential upside of 43.9%.

Disclosure of Interests: Sand Grove Capital Management LLP disclosed a 3.30% interest in Alliance Pharma plc, amounting to 17,823,784 relevant securities as of February 5, 2025.

Recent Dealings: The firm purchased an additional 500,000 shares of Alliance Pharma plc at a price of 61.2p per unit on February 6, 2025.

Market Impact of DeepSeek AI: The recent volatility in the stock market due to China's DeepSeek AI model appears to be stabilizing as major tech companies continue their AI investments, although certain stocks may face significant losses.

JPMorgan's Analysis: JPMorgan highlights potential losers from the DeepSeek AI trade, suggesting that Western firms might adopt new training methods leading to lower costs and a shift in value between application and infrastructure layers in AI.